MECLODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Meclodium patents expire, and what generic alternatives are available?
Meclodium is a drug marketed by Quantum Pharmics and is included in two NDAs.
The generic ingredient in MECLODIUM is meclofenamate sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the meclofenamate sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meclodium
A generic version of MECLODIUM was approved as meclofenamate sodium by MYLAN on September 3rd, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MECLODIUM?
- What are the global sales for MECLODIUM?
- What is Average Wholesale Price for MECLODIUM?
Summary for MECLODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 93 |
| Patent Applications: | 139 |
| DailyMed Link: | MECLODIUM at DailyMed |
US Patents and Regulatory Information for MECLODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | MECLODIUM | meclofenamate sodium | CAPSULE;ORAL | 071380-001 | Jul 14, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Quantum Pharmics | MECLODIUM | meclofenamate sodium | CAPSULE;ORAL | 071381-001 | Jul 14, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
